アブカムでは最適な動作のために Google Chrome など最新ブラウザでの閲覧を推奨します。
corresponding to Human HLA-DR aa 100-200.
This product is a recombinant rabbit monoclonal antibody.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab124809 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Detects a band of approximately 35 kDa (predicted molecular weight: 29 kDa).|
ab124809 has not yet been referenced specifically in any publications.